Showing results (651-660 of 1,398) with videos related to

Sort By:
Pageof 140
Drug Development Research|July 8, 2023
The transcription factor ATF2 promotes gastric cancer progression by activating the METTL3/cyclin D1 pathwayHong Meng, Jing Li, Huapeng Sun, et al.
Drug Development Research|June 9, 2023
Targeting α7 nicotinic acetylcholine receptors and their protein interactions in Alzheimer's disease drug developmentLindsay H Burns, Zhe Pei, Hoau-Yan Wang
Drug Development Research|June 15, 2023
Safety study of topical naltrexone therapy for diabetic skin wounds is confirmed in Göttingen mini-pigsPatricia J McLaughlin, Joseph W Sassani, Ian S Zagon
Drug Development Research|August 3, 2026
Applications of Bioinorganic Nano-Based Delivery Systems-Diagnostics and TherapeuticsFrank Ssengooba, Jubilee Andrew, Donald Fernandes
Drug Development Research|July 30, 2026
TrxR Inhibition and Nrf2-FOXO3 Modulation by Repurposed Drugs: A Redox Strategy to Reverse Cancer Multidrug ResistanceCharan Singh Pawar, Nagarajan Rajendra Prasad
Drug Development Research|September 15, 2023
Artificial intelligence revolutionizing drug development: Exploring opportunities and challengesPrafulla C Tiwari, Rishi Pal, Manju J Chaudhary, et al.
Drug Development Research|June 22, 2026
Identification of Sulfonamide-Based Thiazolidine-2,4-Dione Derivatives as VEGFR-2 and Tumor-Associated hCA IX Inhibitors With Hypoxia-Targeted Anti-Colorectal Cancer ActivityHaytham O Tawfik, Mohammed A Dahab, Mohamed R Elnagar, et al.
Drug Development Research|June 22, 2026
Naphthalene-4H-Chromene Molecular Hybrids as Dual Cholinesterase Inhibitors for the Treatment of Alzheimer's DiseaseVinod Ugale, Nissi Sharon, Chandradip Salunkhe, et al.
Drug Development Research|May 29, 2025
Reactive Oxygen Species (ROS) and Their Profound Influence on Regulating Diverse Aspects of Cancer: A Concise ReviewRachana Tiwari, Ysani Mondal, Khyathi Bharadwaj, et al.
Drug Development Research|July 8, 2026
Design, Synthesis, and Evaluation of the Novel Benzimidazole Derivatives Inspired YC-1 as HIF-1α Inhibitor That Possess Anti-Colon Cancer PotentialQixian Yang, Jing Zhang, Meijing Liu, et al.
Pageof 140